2013

1. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

   Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 482-492